NCT04080700 is a clinical trial of Distal radial approach in Coronary Artery Disease, sponsored by Wonju Severance Christian Hospital.

Who is sponsoring NCT04080700?

NCT04080700 is sponsored by Wonju Severance Christian Hospital.

What drugs are being tested in NCT04080700?

Interventions in NCT04080700: Distal radial approach.

What condition does NCT04080700 study?

NCT04080700 studies Coronary Artery Disease, Radial Artery, Puncture.

Is NCT04080700 still recruiting?

NCT04080700 is currently completed. Last updated 11 May 2022.

Last reviewed 2022-05-11 · How we verify

NCT04080700

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)

Completed Last updated 11 May 2022

What this trial tests

trial testing Distal radial approach in Coronary Artery Disease in 5,000 participants. Completed in 23 January 2022.

Timeline

9 September 2019

Primary endpoint
30 October 2021

23 January 2022

Quick facts

Lead sponsor	Wonju Severance Christian Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	5,000
Start date	9 September 2019
Primary completion	30 October 2021
Estimated completion	23 January 2022
Sites	14 locations across South Korea

Drugs / interventions tested

Distal radial approach

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →
Radial Artery — all drugs for Radial Artery →
Puncture — all drugs for Puncture →

Sponsor

Wonju Severance Christian Hospital

Who can join

20 and older, any sex, with Coronary Artery Disease or Radial Artery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The left distal radial approach (DRA) has been introduced as a feasible and safe alternative route of the radial artery. However, there is still lack of evidence for DRA regarding the feasibility, safety, effective time for hemostasis and hemostasis method. This prospective multicenter registry aimed to investigate the safety and efficacy of DRA for CAG and PCI.

Publications & conference data

7 peer-reviewed publications reference this trial (live from Europe PMC):

Distal transradial access: a review of the feasibility and safety in cardiovascular angiography and intervention.
Cai G, Huang H, Li F, Shi G, et al · · 2020 · cited 45× · PMID 32758150 · DOI 10.1186/s12872-020-01625-8
Distal Radial Access for Coronary Procedures in a Large Prospective Multicenter Registry: The KODRA Trial.
Lee JW, Kim Y, Lee BK, Yoo SY, et al · · 2024 · cited 32× · PMID 38355261 · DOI 10.1016/j.jcin.2023.11.021
Feasibility of Distal Radial Access in High Bleeding Risk Patients Who Underwent Percutaneous Coronary Intervention.
Jin IT, Roh JW, Lee OH, Im E, et al · · 2025 · cited 3× · PMID 39733460 · DOI 10.4070/kcj.2024.0239
Anatomical Snuffbox Versus Dorsum of the Hand for Optimal Access Site in Distal Radial Access: Insight From the KODRA Registry.
Cho SW, Lee JW, Yang TH, Seo JS, et al · · 2026 · cited 1× · PMID 40736380 · DOI 10.4070/kcj.2025.0107
Feasibility of Distal Radial Access in the Use of a Large-Bore Sheath for Percutaneous Coronary Intervention: Real-World Evidence From the Nationwide Cohort.
Jo J, Yoon WS, Jung M, Cho JH, et al · · 2026 · PMID 42204742 · DOI 10.4070/kcj.2025.0478
Impact of obesity on palpation-guided distal radial access for coronary procedures: subgroup analysis of the multicenter, prospective KODRA registry.
Roh JW, Heo SJ, Lee OH, Im E, et al · · 2025 · PMID 40905084 · DOI 10.5603/cj.106255
Distal Radial Access and Women: Implications for Access Site Outcomes in Coronary Procedures.
Roh JW, Heo SJ, Lee OH, Im E, et al · · 2025 · PMID 40207479 · DOI 10.1161/jaha.124.036285

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Wonju Severance Christian Hospital trials

Trials by the same sponsor.

NCT07012499 — QOL and Mental Health Using APD With Remote Monitoring System · NA · enrolling by invitation
NCT07146178 — Long-term Follow-up of Bio-signals and Quality of Recovery Following Implementation of ERAS · NA · not yet recruiting
NCT06675396 — Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients · not yet recruiting
NCT06540430 — Digital Based Home Care Service for Ostomy Patients · NA · not yet recruiting
NCT07017088 — Efficacy of Leuconostoc Mesenteroides · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04080700 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wonju Severance Christian Hospital
Last refreshed: 11 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04080700.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing